Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.53 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 3/20 | 0.53 |
| ▸ | MMP9 | P14780 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7937827 | 1.00 | MME (0.57) | MMEL3MBTL1NPSR1CYP1A2NAALAD2 | |
| SCHEMBL161255 | 1.00 | MME (0.57) | MMEL3MBTL1NPSR1CYP1A2NAALAD2 | |
| SCHEMBL38480 | 1.00 | MME (0.57) | MMEL3MBTL1NPSR1CYP1A2NAALAD2 | |
| Phosphine SCHEMBL28008446 | 0.98 | MME (0.56) | MMEL3MBTL1NPSR1CYP1A2NAALAD2 | |
| Hydrochloric Acid SCHEMBL7323325 | 0.98 | MME (0.56) | MMEL3MBTL1NPSR1CYP1A2NAALAD2 | |
| Hydrochloric Acid SCHEMBL901419 | 0.98 | MME (0.56) | MMEL3MBTL1NPSR1CYP1A2NAALAD2 | |
| Hydrochloric Acid SCHEMBL3905709 | 0.98 | MME (0.56) | MMEL3MBTL1NPSR1CYP1A2NAALAD2 | |
| SCHEMBL1324555 | 0.98 | MME (0.56) | MMEL3MBTL1NPSR1CYP1A2NAALAD2 | |
| SCHEMBL1324550 | 0.98 | MME (0.56) | MMEL3MBTL1NPSR1CYP1A2NAALAD2 | |
| Glycolic Acid SCHEMBL28512694 | 0.93 | NAALAD2 (0.53) | MMEL3MBTL1NPSR1CYP1A2NAALAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4175 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630588-B2 | Bicyclic peptide ligands specific for CD137 | BICYCLETX LIMITED (GB) | 2026-05-19 | — | — | US | claimed |
| WO-2026099897-A1 | NOVEL LINKERS AND ITS PREPARATION METHODS THEREOF | ZYDUS LIFESCIENCES LIMITED (IN) | 2026-05-15 | — | — | WO | claimed |
| US-20260116920-A1 | HUMAN TRANSFERRIN RECEPTOR BINDING PEPTIDE | PEPTIDREAM INC. (JP) | 2026-04-30 | — | — | US | claimed |
| US-12521455-B2 | Kisspeptin receptor (KISS1R) targeted therapeutics and uses thereof | RADIONETICS ONCOLOGY, INC. (US) | 2026-01-13 | — | — | US | claimed |
| US-20250361274-A1 | PEPTIDE AND PEPTIDE-CONTAINING AGENT | PEPTIDREAM INC. (JP) | 2025-11-27 | — | — | US | claimed |
| US-20250312499-A1 | KISSPEPTIN RECEPTOR (KISS1R) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY, INC. | 2025-10-09 | — | — | US | claimed |
| US-20250161408-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2025-05-22 | — | — | US | claimed |
| EP-4541805-A1 | PEPTIDE AND PEPTIDE-CONTAINING AGENT | PeptiDream Inc. (JP) | 2025-04-23 | — | — | EP | claimed |
| US-20250111889-A1 | DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES | UNIVERSITY OF WASHINGTON | 2025-04-03 | — | — | US | claimed |
| US-20250084142-A1 | LONG ACTING PEPTIDE TYROSINE TYROSINE (PYY) ANALOGS AND METHODS OF USE | I2O THERAPEUTICS INC (US) | 2025-03-13 | — | — | US | claimed |
| EP-0030505-B1 | LACTONES SUBSTITUTED BY AN AMINO-ACID RESIDUE, THEIR PREPARATION AND THEIR USE IN THE SEPARATION OF SAID LACTONES OR AMINO ACIDS | ROUSSEL-UCLAF (FR) | 1985-07-24 | — | — | EP | claimed |
| US-4421744-A | OPIATE RECEPTOR ANTAGONISTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-12-20 | — | — | US | claimed |
| EP-0076557-A2 | Peptides and pseudopeptides in which the N terminus bears two substituents | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-04-13 | — | — | EP | claimed |
| US-4273704-A | N-Adamantane-substituted tetrapeptide amides | G. D. SEARLE & CO. (US) | 1981-06-16 | — | — | US | claimed |
| EP-0028716-A2 | Motility increasing peptides and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-05-20 | — | — | EP | claimed |
| US-4247543-A | OLIGOPEPTIDES; ANALGESICS; NERVOUS SYSTEM DISORDERS | SANDOZ LTD. (CH) | 1981-01-27 | — | — | US | claimed |
| US-4177277-A | INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME | E. R. SQUIBB & SONS, INC. (US) | 1979-12-04 | — | — | US | claimed |
| US-4146611-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1979-03-27 | — | — | US | claimed |
| US-4140864-A | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1979-02-20 | — | — | US | claimed |
| US-4128721-A | Amino acid derivatives | E. R. SQUIBB & SONS, INC. (US) | 1978-12-05 | — | — | US | claimed |